Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Exploring salivary proteomes in edentulous patients with type 2 diabetes.

Identifieur interne : 001227 ( PubMed/Curation ); précédent : 001226; suivant : 001228

Exploring salivary proteomes in edentulous patients with type 2 diabetes.

Auteurs : Michael B. Border [États-Unis] ; Sarah Schwartz ; Jim Carlson ; Christopher F. Dibble ; Heidi Kohltfarber ; Steven Offenbacher ; John B. Buse ; Sompop Bencharit

Source :

RBID : pubmed:22314925

Descripteurs français

English descriptors

Abstract

Type 2 diabetes and tooth loss are linked both epidemiologically and pathophysiologically. We applied label-free differential protein expression analysis using multidimensional liquid chromatography/tandem mass spectrometry (2D-LC-MS/MS) to explore the proteomic profile of saliva samples collected from selected type 2 diabetic edentulous patients and non-diabetic controls. Ninety-six peptides corresponding to 52 proteins were differentially expressed between the diabetic edentulous patients and controls (p < 0.05). Some diabetes-related inflammatory biomarkers including glyceraldehyde-3-phosphate dehydrogenase and serum amyloid A were detected with levels increased in diabetic samples. Other biomarkers including amylase, palate, lung and nasal epithelium associated protein (PLUNC), and serotransferrin levels were decreased in diabetic samples. In contrast with previous findings, salivary carbonic anhydrase 6 and alpha-2 macroglobulin levels, however, were decreased in this diabetic patient population. Cluster analysis and principle component analysis demonstrated a differential pattern of protein biomarker expression between diabetic and control subjects. Western blot analysis was completed to confirm the relatively lower expression level of two biomarkers, including PLUNC and amylase in the diabetic group compared to control subjects. The presence of salivary biomarkers specific for diabetes in edentulous subjects mimics those in serum, especially those related to inflammatory/lipid metabolism. While this exploratory study requires further validation with a larger population, it provides proof-of-principle for salivary proteomics for edentulous subjects with diabetes.

DOI: 10.1039/c2mb05079j
PubMed: 22314925

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22314925

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Exploring salivary proteomes in edentulous patients with type 2 diabetes.</title>
<author>
<name sortKey="Border, Michael B" sort="Border, Michael B" uniqKey="Border M" first="Michael B" last="Border">Michael B. Border</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Prosthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599-7450, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Prosthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599-7450</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Schwartz, Sarah" sort="Schwartz, Sarah" uniqKey="Schwartz S" first="Sarah" last="Schwartz">Sarah Schwartz</name>
</author>
<author>
<name sortKey="Carlson, Jim" sort="Carlson, Jim" uniqKey="Carlson J" first="Jim" last="Carlson">Jim Carlson</name>
</author>
<author>
<name sortKey="Dibble, Christopher F" sort="Dibble, Christopher F" uniqKey="Dibble C" first="Christopher F" last="Dibble">Christopher F. Dibble</name>
</author>
<author>
<name sortKey="Kohltfarber, Heidi" sort="Kohltfarber, Heidi" uniqKey="Kohltfarber H" first="Heidi" last="Kohltfarber">Heidi Kohltfarber</name>
</author>
<author>
<name sortKey="Offenbacher, Steven" sort="Offenbacher, Steven" uniqKey="Offenbacher S" first="Steven" last="Offenbacher">Steven Offenbacher</name>
</author>
<author>
<name sortKey="Buse, John B" sort="Buse, John B" uniqKey="Buse J" first="John B" last="Buse">John B. Buse</name>
</author>
<author>
<name sortKey="Bencharit, Sompop" sort="Bencharit, Sompop" uniqKey="Bencharit S" first="Sompop" last="Bencharit">Sompop Bencharit</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22314925</idno>
<idno type="pmid">22314925</idno>
<idno type="doi">10.1039/c2mb05079j</idno>
<idno type="wicri:Area/PubMed/Corpus">001227</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001227</idno>
<idno type="wicri:Area/PubMed/Curation">001227</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001227</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Exploring salivary proteomes in edentulous patients with type 2 diabetes.</title>
<author>
<name sortKey="Border, Michael B" sort="Border, Michael B" uniqKey="Border M" first="Michael B" last="Border">Michael B. Border</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Prosthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599-7450, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Prosthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599-7450</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Schwartz, Sarah" sort="Schwartz, Sarah" uniqKey="Schwartz S" first="Sarah" last="Schwartz">Sarah Schwartz</name>
</author>
<author>
<name sortKey="Carlson, Jim" sort="Carlson, Jim" uniqKey="Carlson J" first="Jim" last="Carlson">Jim Carlson</name>
</author>
<author>
<name sortKey="Dibble, Christopher F" sort="Dibble, Christopher F" uniqKey="Dibble C" first="Christopher F" last="Dibble">Christopher F. Dibble</name>
</author>
<author>
<name sortKey="Kohltfarber, Heidi" sort="Kohltfarber, Heidi" uniqKey="Kohltfarber H" first="Heidi" last="Kohltfarber">Heidi Kohltfarber</name>
</author>
<author>
<name sortKey="Offenbacher, Steven" sort="Offenbacher, Steven" uniqKey="Offenbacher S" first="Steven" last="Offenbacher">Steven Offenbacher</name>
</author>
<author>
<name sortKey="Buse, John B" sort="Buse, John B" uniqKey="Buse J" first="John B" last="Buse">John B. Buse</name>
</author>
<author>
<name sortKey="Bencharit, Sompop" sort="Bencharit, Sompop" uniqKey="Bencharit S" first="Sompop" last="Bencharit">Sompop Bencharit</name>
</author>
</analytic>
<series>
<title level="j">Molecular bioSystems</title>
<idno type="eISSN">1742-2051</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Biomarkers (analysis)</term>
<term>Blotting, Western</term>
<term>Carbonic Anhydrases (analysis)</term>
<term>Chromatography, Liquid (methods)</term>
<term>Cluster Analysis</term>
<term>Diabetes Mellitus, Type 2 (complications)</term>
<term>Diabetes Mellitus, Type 2 (metabolism)</term>
<term>Diabetes Mellitus, Type 2 (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Mouth, Edentulous (complications)</term>
<term>Mouth, Edentulous (metabolism)</term>
<term>Proteome (analysis)</term>
<term>Proteomics (methods)</term>
<term>Saliva (chemistry)</term>
<term>Serum Amyloid A Protein (analysis)</term>
<term>Tandem Mass Spectrometry (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Analyse de regroupements</term>
<term>Bouche édentée ()</term>
<term>Bouche édentée (métabolisme)</term>
<term>Carbonic anhydrases (analyse)</term>
<term>Chromatographie en phase liquide ()</term>
<term>Diabète de type 2 ()</term>
<term>Diabète de type 2 (métabolisme)</term>
<term>Diabète de type 2 (physiopathologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Marqueurs biologiques (analyse)</term>
<term>Mâle</term>
<term>Protéine amyloïde A sérique (analyse)</term>
<term>Protéome (analyse)</term>
<term>Protéomique ()</term>
<term>Salive ()</term>
<term>Spectrométrie de masse en tandem ()</term>
<term>Sujet âgé</term>
<term>Technique de Western</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Biomarkers</term>
<term>Carbonic Anhydrases</term>
<term>Proteome</term>
<term>Serum Amyloid A Protein</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Carbonic anhydrases</term>
<term>Marqueurs biologiques</term>
<term>Protéine amyloïde A sérique</term>
<term>Protéome</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Diabetes Mellitus, Type 2</term>
<term>Mouth, Edentulous</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Diabetes Mellitus, Type 2</term>
<term>Mouth, Edentulous</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Chromatography, Liquid</term>
<term>Proteomics</term>
<term>Tandem Mass Spectrometry</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Bouche édentée</term>
<term>Diabète de type 2</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Diabète de type 2</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Diabetes Mellitus, Type 2</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Blotting, Western</term>
<term>Cluster Analysis</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Analyse de regroupements</term>
<term>Bouche édentée</term>
<term>Chromatographie en phase liquide</term>
<term>Diabète de type 2</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Protéomique</term>
<term>Salive</term>
<term>Spectrométrie de masse en tandem</term>
<term>Sujet âgé</term>
<term>Technique de Western</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Type 2 diabetes and tooth loss are linked both epidemiologically and pathophysiologically. We applied label-free differential protein expression analysis using multidimensional liquid chromatography/tandem mass spectrometry (2D-LC-MS/MS) to explore the proteomic profile of saliva samples collected from selected type 2 diabetic edentulous patients and non-diabetic controls. Ninety-six peptides corresponding to 52 proteins were differentially expressed between the diabetic edentulous patients and controls (p < 0.05). Some diabetes-related inflammatory biomarkers including glyceraldehyde-3-phosphate dehydrogenase and serum amyloid A were detected with levels increased in diabetic samples. Other biomarkers including amylase, palate, lung and nasal epithelium associated protein (PLUNC), and serotransferrin levels were decreased in diabetic samples. In contrast with previous findings, salivary carbonic anhydrase 6 and alpha-2 macroglobulin levels, however, were decreased in this diabetic patient population. Cluster analysis and principle component analysis demonstrated a differential pattern of protein biomarker expression between diabetic and control subjects. Western blot analysis was completed to confirm the relatively lower expression level of two biomarkers, including PLUNC and amylase in the diabetic group compared to control subjects. The presence of salivary biomarkers specific for diabetes in edentulous subjects mimics those in serum, especially those related to inflammatory/lipid metabolism. While this exploratory study requires further validation with a larger population, it provides proof-of-principle for salivary proteomics for edentulous subjects with diabetes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">22314925</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1742-2051</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>8</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2012</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Molecular bioSystems</Title>
<ISOAbbreviation>Mol Biosyst</ISOAbbreviation>
</Journal>
<ArticleTitle>Exploring salivary proteomes in edentulous patients with type 2 diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>1304-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1039/c2mb05079j</ELocationID>
<Abstract>
<AbstractText>Type 2 diabetes and tooth loss are linked both epidemiologically and pathophysiologically. We applied label-free differential protein expression analysis using multidimensional liquid chromatography/tandem mass spectrometry (2D-LC-MS/MS) to explore the proteomic profile of saliva samples collected from selected type 2 diabetic edentulous patients and non-diabetic controls. Ninety-six peptides corresponding to 52 proteins were differentially expressed between the diabetic edentulous patients and controls (p < 0.05). Some diabetes-related inflammatory biomarkers including glyceraldehyde-3-phosphate dehydrogenase and serum amyloid A were detected with levels increased in diabetic samples. Other biomarkers including amylase, palate, lung and nasal epithelium associated protein (PLUNC), and serotransferrin levels were decreased in diabetic samples. In contrast with previous findings, salivary carbonic anhydrase 6 and alpha-2 macroglobulin levels, however, were decreased in this diabetic patient population. Cluster analysis and principle component analysis demonstrated a differential pattern of protein biomarker expression between diabetic and control subjects. Western blot analysis was completed to confirm the relatively lower expression level of two biomarkers, including PLUNC and amylase in the diabetic group compared to control subjects. The presence of salivary biomarkers specific for diabetes in edentulous subjects mimics those in serum, especially those related to inflammatory/lipid metabolism. While this exploratory study requires further validation with a larger population, it provides proof-of-principle for salivary proteomics for edentulous subjects with diabetes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Border</LastName>
<ForeName>Michael B</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Department of Prosthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599-7450, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwartz</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carlson</LastName>
<ForeName>Jim</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dibble</LastName>
<ForeName>Christopher F</ForeName>
<Initials>CF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kohltfarber</LastName>
<ForeName>Heidi</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Offenbacher</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Buse</LastName>
<ForeName>John B</ForeName>
<Initials>JB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bencharit</LastName>
<ForeName>Sompop</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL092338</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1RR025747</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>02</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mol Biosyst</MedlineTA>
<NlmUniqueID>101251620</NlmUniqueID>
<ISSNLinking>1742-2051</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020543">Proteome</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000685">Serum Amyloid A Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.2.1.1</RegistryNumber>
<NameOfSubstance UI="D002256">Carbonic Anhydrases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.2.1.1</RegistryNumber>
<NameOfSubstance UI="C477051">carbonic anhydrase VI</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002256" MajorTopicYN="N">Carbonic Anhydrases</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009066" MajorTopicYN="N">Mouth, Edentulous</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000685" MajorTopicYN="N">Serum Amyloid A Protein</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>2</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>2</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>6</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22314925</ArticleId>
<ArticleId IdType="doi">10.1039/c2mb05079j</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001227 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001227 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22314925
   |texte=   Exploring salivary proteomes in edentulous patients with type 2 diabetes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22314925" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a EdenteV2 

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022